arrow
J

James D. Brien

University of Kentucky
H指数:36
被引数:4,894

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting the Zika virus envelope domains I and III as a recombinant vaccine protects mice from lethal challenge

靶向寨卡病毒包膜结构域I和III的重组疫苗保护小鼠免受致死性攻击

2026-04-140
OAAI
CD4+ T Cells Are Key to Shaping a Protective Humoral Immunity in Primary Dengue 2 Virus Infection: Implications for Rational Vaccine Design

CD4+ T细胞对于塑造原发性登革2病毒感染中的保护性体液免疫至关重要:对理性疫苗设计的启示

2025-10-290
OAAI
COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort
2024-06-140
OAAI
Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population (vol 14, 1241038, 2023)

哥伦比亚人群对Mu和 γ SARS-CoV-2变体的交叉反应性体液和CD4 T细胞反应 (第14卷,1241038,2023)

2023-08-160
OAAI
Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population

哥伦比亚人群对Mu和 γ SARS-CoV-2变体的交叉反应性体液和CD4 T细胞反应

2023-07-274
OAAI
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
MSPHERE
IF3.1
2022-08-3118
OAAI
Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies
2022-04-276
OAAI
Function Is More Reliable Than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination
2021-09-3021
OAAI
Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge

单剂量鼻内给药AdCOVID可引起针对SARS-CoV-2的全身和粘膜免疫,并充分保护小鼠免受致死性攻击

2021-08-0971
OAAI